Remission maintenance of adult acute lymphoblastic leukemia

James O. Armitage, C. Patrick Burns

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400 rads cranial irradiation and intrathecal methotrexate for CNS prophylaxis followed by continuation systemic chemotherapy with oral methotrexate, 6‐mercaptopurine and cyclophosphamide. There were no CNS relapses following treatment. One‐half of the patients relapsed within 11 months, with 5 patients remaining in remission for 27+ to 31+ months. The toxicity was acceptable with no treatment‐related deaths. This regimen is capable of producing long remissions in a significant proportion of adults with acute lymphoblastic leukemia and appears to be effective in reducing the incidence of CNS relapse. It has the additional advantage of ease of administration and can be largely administered in the community.

Original languageEnglish (US)
Pages (from-to)53-58
Number of pages6
JournalMedical and Pediatric Oncology
Volume3
Issue number1
DOIs
StatePublished - 1977

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Central Nervous System
Maintenance
Methotrexate
Cranial Irradiation
Recurrence
Combination Drug Therapy
Cyclophosphamide
Drug Therapy
Incidence
Therapeutics

Keywords

  • acute lymphoblastic leukemia
  • adult CNS leukemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Remission maintenance of adult acute lymphoblastic leukemia. / Armitage, James O.; Burns, C. Patrick.

In: Medical and Pediatric Oncology, Vol. 3, No. 1, 1977, p. 53-58.

Research output: Contribution to journalArticle

@article{9698484da1dd47ada8484d6d8b339f3e,
title = "Remission maintenance of adult acute lymphoblastic leukemia",
abstract = "This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400 rads cranial irradiation and intrathecal methotrexate for CNS prophylaxis followed by continuation systemic chemotherapy with oral methotrexate, 6‐mercaptopurine and cyclophosphamide. There were no CNS relapses following treatment. One‐half of the patients relapsed within 11 months, with 5 patients remaining in remission for 27+ to 31+ months. The toxicity was acceptable with no treatment‐related deaths. This regimen is capable of producing long remissions in a significant proportion of adults with acute lymphoblastic leukemia and appears to be effective in reducing the incidence of CNS relapse. It has the additional advantage of ease of administration and can be largely administered in the community.",
keywords = "acute lymphoblastic leukemia, adult CNS leukemia",
author = "Armitage, {James O.} and Burns, {C. Patrick}",
year = "1977",
doi = "10.1002/mpo.2950030108",
language = "English (US)",
volume = "3",
pages = "53--58",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Remission maintenance of adult acute lymphoblastic leukemia

AU - Armitage, James O.

AU - Burns, C. Patrick

PY - 1977

Y1 - 1977

N2 - This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400 rads cranial irradiation and intrathecal methotrexate for CNS prophylaxis followed by continuation systemic chemotherapy with oral methotrexate, 6‐mercaptopurine and cyclophosphamide. There were no CNS relapses following treatment. One‐half of the patients relapsed within 11 months, with 5 patients remaining in remission for 27+ to 31+ months. The toxicity was acceptable with no treatment‐related deaths. This regimen is capable of producing long remissions in a significant proportion of adults with acute lymphoblastic leukemia and appears to be effective in reducing the incidence of CNS relapse. It has the additional advantage of ease of administration and can be largely administered in the community.

AB - This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400 rads cranial irradiation and intrathecal methotrexate for CNS prophylaxis followed by continuation systemic chemotherapy with oral methotrexate, 6‐mercaptopurine and cyclophosphamide. There were no CNS relapses following treatment. One‐half of the patients relapsed within 11 months, with 5 patients remaining in remission for 27+ to 31+ months. The toxicity was acceptable with no treatment‐related deaths. This regimen is capable of producing long remissions in a significant proportion of adults with acute lymphoblastic leukemia and appears to be effective in reducing the incidence of CNS relapse. It has the additional advantage of ease of administration and can be largely administered in the community.

KW - acute lymphoblastic leukemia

KW - adult CNS leukemia

UR - http://www.scopus.com/inward/record.url?scp=0017347316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017347316&partnerID=8YFLogxK

U2 - 10.1002/mpo.2950030108

DO - 10.1002/mpo.2950030108

M3 - Article

C2 - 264999

AN - SCOPUS:0017347316

VL - 3

SP - 53

EP - 58

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 1

ER -